vTv Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $17 | $0 | $0 | $1,000 |
Gross Profit | 17 | -23 | 978 | |
EBITDA | -4,415 | -5,818 | -6,386 | -5,605 |
EBIT | -4,437 | -5,840 | -6,409 | -5,627 |
Net Income | -3,634 | -4,783 | -5,180 | -4,865 |
Net Change In Cash | 17 | 0 | 0 | 1,000 |
Free Cash Flow | -4,825 | -6,418 | -6,729 | -7,335 |
Cash | 36,746 | 41,571 | 45,526 | 52,255 |
Basic Shares | 5,771 | 5,456 | 6,403 | 4,141 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,017 | $9 | $2,018 | $4,005 |
Gross Profit | 1,017 | -13,595 | 1,926 | 3,916 |
EBITDA | -22,516 | -25,412 | -24,766 | -17,515 |
EBIT | -22,605 | -25,502 | -24,858 | -17,604 |
Net Income | -18,462 | -20,250 | -25,073 | -17,731 |
Net Change In Cash | 1,017 | 9 | 2,018 | 4,005 |
Cost of Revenue | -1,289 | |||
Free Cash Flow | -25,307 | -19,081 | -16,043 | -19,308 |
Cash | 36,746 | 9,446 | 12,126 | 13,415 |
Basic Shares | 5,771 | 2,084 | 1,919 | 1,566 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.55 |
2024-09-30 | -$0.87 |
2024-06-30 | -$0.80 |
2024-03-31 | -$1.17 |
